1.
Hường NTT, Thắng HM. Factors related to the outcomes of adjuvant capecitabin monotherapy for high-risk stage II colon cancer. TCNCYH [Internet]. 2024Oct.15 [cited 2025Apr.4];182(9):105-11. Available from: https://tapchinghiencuuyhoc.vn/index.php/tcncyh/article/view/2691